GRI Bio, Inc.
corporate_fare Company Profile
GRI Bio, Inc. (NASDAQ:GRI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for GRI at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- GRI Bio Expands At-The-Market Offering to $7.38M, Indicating Substantial Dilution
- GRI Bio Reports Positive Phase 2a Data for IPF Drug, Confirms Nasdaq Equity Compliance
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$11.96M
Diluted EPS
-$121.80
Op. Cash Flow
-$10.19M
Free Cash Flow
-$10.19M
Operating Income
-$11.98M
Cash & Equivalents
$8.23M
Debt / Equity
0.00×
Shares Outstanding
497.69K sh
Source: 10-K · filed 2026-01-30 · accession 0001824293-26-000033
show_chartPrice Chart
Loading chart...